pcDNA3-HA-cyclin E2 Citations (3)

Originally described in: Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins.
Zariwala M, Liu J, Xiong Y Oncogene. 1998 Nov 26. 17(21):2787-98. PubMed Journal

---

Articles Citing pcDNA3-HA-cyclin E2

Articles
Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis. Wang L, Ho J, Glackin C, Martins-Green M. Transl Oncol. 2012 Oct;5(5):344-55. Epub 2012 Oct 1. PubMed
HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway. Smith AE, Ferraro E, Safonov A, Morales CB, Lahuerta EJA, Li Q, Kulick A, Ross D, Solit DB, de Stanchina E, Reis-Filho J, Rosen N, Arribas J, Razavi P, Chandarlapaty S. Nat Commun. 2021 Nov 18;12(1):6667. doi: 10.1038/s41467-021-27093-y. PubMed
Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors. Merk DJ, Tsiami F, Hirsch S, Walter B, Haeusser LA, Maile JD, Stahl A, Jarboui MA, Lechado-Terradas A, Klose F, Babaei S, Admard J, Casadei N, Roggia C, Spohn M, Schittenhelm J, Singer S, Schuller U, Piccioni F, Persky NS, Claassen M, Tatagiba M, Kahle PJ, Root DE, Templin M, Tabatabai G. Genome Biol. 2024 Dec 2;25(1):301. doi: 10.1186/s13059-024-03438-w. PubMed

If you have published an article using this material, please email us at to have your article added to this page.